EndoGastric Solutions Lands $30M

San Mateo-based EndoGastric Solutions, a developer of reconstructive treatments for gastroesophageal reflux disease (GERD), has raised $30M in a new funding round, the company said this week. The funding came from existing investors, including dvanced Technology Ventures, Canaan Partners, Chicago Growth Partners, De Novo Ventures, Foundation Medical Partners, Oakwood Medical Investors and Radius Ventures. EndoGastric said the funding was a Series G round. More information »